A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Yazar: | Sorno, Rubina Haque |
---|---|
Diğer Yazarlar: | Khair, Nishat Zareen |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2024
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/23842 |
Benzer Materyaller
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Yazar:: Khan, Muidul Hasan
Baskı/Yayın Bilgisi: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
Yazar:: Ruhee, Noshin Nawer
Baskı/Yayın Bilgisi: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
Yazar:: Raju, Md. Ismail
Baskı/Yayın Bilgisi: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)